Spots Global Cancer Trial Database for temozolomide 60 mg x 21 days
Every month we try and update this database with for temozolomide 60 mg x 21 days cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Veliparib and Temozolomide in Treating Patients With Recurrent Glioblastoma | NCT01026493 | Brain and Centr... | temozolomide 60... temozolomide 75... ABT-888 20 mg x... ABT-888 40 mg x... Temozolomide 15... ABT-888 40 mg x... | 18 Years - 120 Years | Radiation Therapy Oncology Group | |
Veliparib and Temozolomide in Treating Patients With Recurrent Glioblastoma | NCT01026493 | Brain and Centr... | temozolomide 60... temozolomide 75... ABT-888 20 mg x... ABT-888 40 mg x... Temozolomide 15... ABT-888 40 mg x... | 18 Years - 120 Years | Radiation Therapy Oncology Group |